Imax has experienced significant growth, with its stock reaching $54.79, an increase of nearly 80% over the past year. The company's box office performance has been bolstered by films like 'The Odyssey,' which surpassed $400 million in global ticket sales, accounting for nearly 30% of the film's total earnings despite Imax screens representing less than 1% of all movie screens.
Analysts predict that Imax could set a new global box office record in 2026, following a record $1.28 billion in sales last year. The company's premium ticket prices, averaging $20.57 in the U.S., have not deterred audiences, and its expansion plans include installing 160 to 175 new Imax systems in 2026.
Despite this momentum, potential buyers face challenges, particularly major studios that would have conflicts of interest if they acquired Imax, as the company serves all studios equally. While tech companies like Netflix, Apple, and Amazon could be interested, their historical reluctance to engage in traditional theatrical models complicates matters.
Analysts suggest that Imax may remain independent for now, as its elevated stock price makes it a more expensive acquisition target than it was a year ago